CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 2.97: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
13.49%Above 5Y avg (11.48%)
Annual Rate
HKD 0.34Paid annual
Payout Ratio
134.5%High
Last Ex-Dividend
Jun 16, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
2.51BHKD320.46M · vs all stocks (USD)
Trailing P/E
7.75xRevenue (TTM)
1.10BCNY139.91M · vs all stocks (USD)
Profit Margin
26.63%Beta
-0.1850xvs all stocks
52-Week Change
-29.06%vs all stocks
Market Capitalization
2.51BHKD320.46M · vs all stocks (USD)
Enterprise Value
2.20BHKD280.02M · vs all stocks (USD)
Trailing P/E
7.75xPrice to Sales (TTM)
2.43xPrice to Book (MRQ)
1.43xEnterprise to Revenue
2.00xEnterprise to EBITDA
5.60xProfit Margin
26.63%Operating Margin
35.79%Return on Assets (TTM)
8.44%Return on Equity (TTM)
17.67%Revenue (TTM)
1.10BCNY139.91M · vs all stocks (USD)
Revenue per Share (TTM)
1.28CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-5.50%Gross Profit (TTM)
834.22MCNY106.35M · vs all stocks (USD)
EBITDA (TTM)
377.08MCNY48.07M · vs all stocks (USD)
Net Income (TTM)
292.26MCNY37.26M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-9.20%Operating Cash Flow (TTM)
143.47MCNY18.29M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-17.60MCNY-2.24M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.3400HKDUpdated Aug 21, 2026Trailing Annual Dividend Yield
13.49%vs all stocks
5-Year Average Dividend Yield
11.48%vs all stocks
Payout Ratio
134.46%Revenue
943.26MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
226.25MCNYFY2025 · Dec 31, 2025Gross Profit
717.01MCNYFY2025 · Dec 31, 2025Operating Income
316.35MCNY47.04M · vs all stocks (USD)
Pre-tax Income
328.86MCNYFY2025 · Dec 31, 2025Income Tax Expense
77.66MCNYFY2025 · Dec 31, 2025Net Income
251.20MCNYFY2025 · Dec 31, 2025EBIT
343.24MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
377.08MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
410.30MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
22.65MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
14.38MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
236.85MCNYFY2025 · Dec 31, 2025Free Cash Flow
191.85MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
916.01MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
328.86MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-8.26MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-77.39MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-6.35MCNYFY2025 · Dec 31, 2025Capital Expenditures
-45.00MCNYFY2025 · Dec 31, 2025Purchase of Investments
-72.27MCNYFY2025 · Dec 31, 2025Sale of Investments
62.25MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-55.02MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
670.54MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-514.71MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-338.66MCNYFY2025 · Dec 31, 2025Other Financing Charges
-46.08MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-228.90MCNYFY2025 · Dec 31, 2025Shares Outstanding
739.30MSharesUpdated Aug 21, 2026Float Shares
223.29MSharesUpdated Aug 21, 2026% Held by Insiders
69.80%vs all stocks
% Held by Institutions
0.51%vs all stocks
Total Cash (MRQ)
1.15BCNY146.59M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.34CNYUpdated Aug 21, 2026Total Debt (MRQ)
679.78MCNY86.66M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4244xCurrent Ratio (MRQ)
2.17xBook Value per Share (MRQ)
2.17CNYUpdated Aug 21, 2026Total Assets
2.29BCNY340.40M · vs all stocks (USD)
Total Current Assets
1.78BCNYFY2025 · Dec 31, 2025Total Liabilities
912.38MCNYFY2025 · Dec 31, 2025Total Non-current Assets
513.36MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
94.10MCNYFY2025 · Dec 31, 2025Total Current Liabilities
818.28MCNYFY2025 · Dec 31, 2025Cash
916.01MCNYFY2025 · Dec 31, 2025Cash Equivalents
52.27MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
968.28MCNYFY2025 · Dec 31, 2025Other Short-term Investments
20.00MCNYFY2025 · Dec 31, 2025Accounts Receivable
172.97MCNYFY2025 · Dec 31, 2025Inventory
70.29MCNYFY2025 · Dec 31, 2025Accounts Payable
18.77MCNYFY2025 · Dec 31, 2025Short-term Debt
514.25MCNYFY2025 · Dec 31, 2025Long-term Debt
70.02MCNYFY2025 · Dec 31, 2025Common Stock (Book)
113.00KCNYFY2025 · Dec 31, 2025Retained Earnings
231.78MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.38BCNY204.72M · vs all stocks (USD)
52-Week Low
2.30HKDUpdated Aug 21, 202652-Week High
3.80HKDUpdated Aug 21, 202652-Week Change
-29.06%vs all stocks
Beta
-0.1850xvs all stocks
50-Day MA
3.17HKDUpdated Aug 21, 2026200-Day MA
3.31HKDUpdated Aug 21, 2026Avg 10-Day Volume
314.90KSharesUpdated Aug 21, 2026Avg 30-Day Volume
223.85KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.4000CNYUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 37,260,397.854Operating Cash Flow (USD, TTM): 18,290,521.392
Financial Health
Altman Z-Score 2.97: safe zoneNotable
Altman Z-Score: 2.97
High structural barrier to entryNotable
Barrier to Entry: 0.64
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tellgen Corporation
Tier 1ProductionApproval-Gated PipelineRule
Dishman Carbogen Amcis Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Shin Poong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Santhera Pharmaceuticals Holding AG
Tier 1ProductionApproval-Gated PipelineRuleRisk
Medy-Tox Inc.
Tier 1ProductionApproval-Gated PipelineRule
Newron Pharmaceuticals SpA
Tier 1ProductionApproval-Gated PipelineRuleRisk
Animalcare Group Plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
Allgens Medical Technology Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Lyell Immunopharma, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Hubei Jumpcan Pharmaceutical Co., Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
CIE Automotive India Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Manhattan Associates Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities